|
|
100 North Fairway Drive, Suite 134
Vernon Hills, IL 60061 USA
phone:847-362-8200
fax:847-362-8394
|
|
| Symbol |
private |
| Founded |
0 |
| Employees |
|
|
|
| www.winstonlabs.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Therapeutics for managing and alleviating pain. |
|
| Management |
| Joel E. Bernstein, M.D., Chief Executive Officer; Scott B. Phillips, M.D., Senior Vice President, Scientific Affairs; David Starr, Vice President, Chief Financial Officer; David A. Henninger, M.S., Vice President, Operations; |
| |
|
|
| |
|
| Keywords |
| pain management, neuroactive compounds, neurotransmitters, osteoarthritis, cluster headache, migraine headache, chronic daily headache, neuropathic pain syndromes, mucositis, cancer pain, PainManagement |
|
|
|
| Description |
|
Winston Laboratories, Inc. is a research-based company that discovers, develops, and commercializes innovative therapeutics for pain. |
|
| Products / Services |
The company is developing new medications for conditions such as osteoarthritis, cluster headache, migraine headache, chronic daily headache, neuropathic pain syndromes (including painful diabetic neuropathy and postherpetic neuralgia), mucositis, and cancer pain.
|
|
| Technology / Differentiation |
| The company's proprietary technologies involve neuroactive compounds which affect the functioning of neurotransmitters that control and mediate pain transmission, most importantly substance P, calcitonin gene-related peptide (CGRP), histamine, and serotonin. |
|
|
| Strategy |
Winston does not intend to establish any sales and marketing infrastructure outside of the United States in the foreseeable future. Winston plans to out-license the marketing rights to its products in territories outside the United States.
For several of the products in Winston's pipeline, specifically those indicated for conditions with large patient populations who are mainly treated by general practitioners and internists, Winston seeks larger marketing partners within the United States.
|
|
| Status |
| The company's pipeline includes four product candidates in clinical testing and two in preclinical testing. |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members